Design, build, and validate two sub-diffraction quantum-inspired imaging device (SQUIID)-enabled microscopes to address a critical need in biomedical imaging
Active Project Grant Awarded
- Award ID
- 60NANB26D094
- Recipient
-
H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. UEI DVHKP4N619V9
- Awarding agency
-
National Institute of Standards and Technology
Department of Commerce
- Obligated
- $750,000
Award facts
- Assistance listing
- 11.617 Congressionally-Identified Projects
- Completion date 11% complete
- Place of performance
- Tampa, FL 33612, USA
Award details come from USAspending.gov.
About this award
The National Institute of Standards and Technology awarded H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. $750,000 on August 28, 2026, under Project Grant 60NANB26D094 in the Congressionally-Identified Projects program (CFDA 11.617). The award funds the design, build, and validation of two sub-diffraction quantum-inspired imaging device (SQUIID)-enabled microscopes for biomedical imaging, with advanced cancer studies as the intended use. The recipient will purchase two Nikon Ti2-E inverted microscope platforms and engineer the sub-diffraction optical system, covering design, photonic lantern fabrication, computational imaging development, instrument integration, and calibration. One complete system will be installed at the cancer center, and collaborative biological imaging studies will demonstrate utility and performance. One microscope will be used for further optimization and one deployed for biological studies. If successful, the microscopes will achieve image reconstruction approaching one-tenth the diffraction limit while separating ten or more biomarkers.
The recipient plans to subaward funds to the University of Central Florida to develop a SQUIID modification upgrade for a commercial microscope. Moffitt is the main beneficiary, and the University of Central Florida is the secondary beneficiary.
Place of performance is Tampa, Florida 33612. The period of performance runs from the August 28, 2026 award date to an ultimate completion date of September 30, 2028.
The Congressionally-Identified Projects program assists organizations that Congress identifies in appropriations legislation to achieve objectives Congress specifies, and renewals depend on future Congressional funding.
Description
- Purpose
- The purpose of this grant is to design, build, and validate two sub-diffraction quantum-inspired imaging device (SQUIID)-enabled microscopes to address a critical need in biomedical imaging. One microscope will be used for further optimization, and one will be deployed for biological studies. Sub-diffraction imaging is paramount for future advanced biomedical applications, including cancer studies.
- Activities
- Two nikon TI2-E inverted microscope platforms will be purchased. The sub-diffraction optical system will be engineered and built, including design, photonic lantern fabrication, computational imaging development, instrument integration, and calibration. One complete system will be installed at the cancer center. Collaborative biological imaging studies will be performed to demonstrate utility and performance.
- Expected outcomes
- If successful, the squiid-enabled microscopes will achieve image reconstruction approaching one-tenth the diffraction limit while separating ten or more biomarkers. This instrument can be potentially used in many BIO-imaging applications, and its intended use is for advanced cancer studies.
- Intended beneficiaries
- The main beneficiary will be moffitt cancer center, which will be able to enhance its research capabilities in advanced cancer studies. The secondary beneficiary is the university of central florida, which will be subcontracted to make a modification to a commercial microscope. Ultimately, residents of florida, and, more broadly, the general population of the U.S., may benefit from improved diagnostics and cure of cancer. As such, scientific developments resultant from this funding should impact beyond the individual institutions, local communities, and the state of florida.
- Subrecipient activities
- The recipient plans to subaward funds to conduct the development of squiid modification upgrade for a commercial microscope as a part of this research project. The subrecipient is identified as the university of central florida (UCF).
Quick answers
Who received award 60NANB26D094?
60NANB26D094 was awarded to H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. by National Institute of Standards and Technology (Department of Commerce) on August 28, 2026.
How much is award 60NANB26D094 worth?
$750,000 has been obligated on 60NANB26D094.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award